| ID | Sequence | Length | GC content |
|---|---|---|---|
| GUGGUUAUCACAUUAAUUCGUGCCUCAAUGAAUGAAUGAAUGGACAAAC… | 662 nt | 0.4109 | |
| GUCUCCUAGCAACGGCGGGUAGCGUUGUUGACAUCCCGGGAGGCUGUGC… | 628 nt | 0.4220 |
Predicted to enable dynein intermediate chain binding activity. Predicted to be involved in microtubule-based movement. Predicted to be located in ciliary tip. Predicted to be part of cytoplasmic dynein complex. Predicted to be active in centrosome and cytoplasm. Biomarker of hepatocellular carcinoma. [provided by Alliance of Genome Resources, Jul 2025]
A study in newborn rats demonstrated that the DYNLRB2 is a highly expressed RNA marker used for the identification of ependymal cells in the brain following hypoxic-ischemic encephalopathy [Chen et al. DOI:10.1096/fj.202402891RR].